Search results
-
Croda joins the Together for Sustainability initiative
Croda becomes the 30th member of TfS
-
Chief Executive's Statement 2025
An overview from Steve Foots, our Chief Executive, outlining the year’s key achievements, business performance, strategic priorities, and future outlook for growth and innovation.
-
Contract for innovative delivery system for COVID19 vaccine
We have recently entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate.
-
Croda invests in biopharma innovation with expanded Super Refined™ facility in Leek, UK
25 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, continues to invest in the evolving world of biopharmaceutical manufacturing where consistency and purity in ingredients are critical.
-
Croda’s first product launch specifically focusing on the biopesticide market
28 September 2023: Croda has launched the new product Atlox™ BS-50, a delivery system which specifically meets the needs of the growing biopesticide market.
-
Record performance driven by accelerated strategic implementation
Croda International results for the six months ended 30 June 2021
-
First quarter 2025 sales update
23 April 2025: Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the first quarter of 2025 (the three months ended 31 March 2025).
-
Steve Foots, Group Chief Executive Letter
We are focused on delivery and modernisation, ensuring rigorous cost discipline and driving operational efficiencies to continue our long record of strong performance.
-
Croda acquires Inventiva, encapsulation and delivery system technology
It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.
-
Procurement and sustainable sourcing
Using natural resources brings a responsibility to ensure no associated negative social or environmental impacts, and an opportunity to advocate and contribute to positive change.
-
Sustainability
Sustainability spans every area of our business and is a crucial way we add value to our customers.
-
Shaping the next generation: Industrial Placements at Croda
Join us as we recognise our Industrial Placement students, their success and their views on our placement opportunities.
-
Specialist biotechnology capabilities
At Croda, thanks to our expertise across a wide range of biotechnology specialisms, we are developing new, innovative and sustainable ingredients to support our customers in bringing to market exciting often niche products.
-
Meet the expert: Will Small, Research & Technology Specialist
Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.
-
Strengthening Life Sciences with the acquisition of Avanti Polar Lipids
A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.
-
Strategic investment Entekno Materials
A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.
-
Australia
The availability of high quality wool grease, the raw material from which lanolin is manufactured, fuelled Croda’s move into Australia in 1968.
-
C4C Lead via SnapEngage
C4C Lead via SnapEngage
-
Life Sciences
We provide high-quality healthcare solutions, protect crops, and enhance seeds, supporting global health and crop sustainability. Our growing range of technologies ensures we deliver high value to customers worldwide.
-
Consumer Care
Consumer Care combines our businesses closest to consumers, offering innovative, sustainable solutions for home care, beauty, personal care, and fragrance. Our expertise enables us to provide tailored formulations to meet global consumer demands.